Shusen Sun

Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research

Vibhu Paudyal, Shusen Sun, Rabia Hussain et al. · Research in Social and Administrative Pharmacy · 2021 · 125 citations · Full text

Public Affairs, Pharmaceutical Policy, Pharmacotherapy +12

Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System

Jing Huang, Long Meng, Bing Yang et al. · Scientific Reports · 2020 · 71 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16

Assessing fluoroquinolone‐associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system

Long Meng, Jing Huang, Yuntao Jia et al. · International Journal of Clinical Practice · 2019 · 64 citations

Pharmacy, Pharmacology, Clinical Epidemiology +16

Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system

Jing Huang, Yuntao Jia, Shusen Sun et al. · BMC Pharmacology and Toxicology · 2020 · 55 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16

Cannabinoid Hyperemesis Syndrome

Shusen Sun, Anthony E. Zimmermann · Hospital Pharmacy · 2013 · 51 citations · Full text

Medicine, Clinical Pharmacy, Emergency Medicine +17